Straits Times Index
3,292.69 +10.64 (+0.32%) Nikkei
38,405.66 +470.90 (+1.24%) Hang Seng
17,763.03 +16.12 (+0.09%) FTSE 100
8,144.13 -2.90 (-0.04%) Bitcoin USD
62,955.66 -677.18 (-1.06%) CMC Crypto 200
1,292.39 -46.67 (-3.48%)
Ekso Bionics Holdings, Inc. (0IFR.L)
| Previous close | 1.1980 |
| Open | 0.0000 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,151 |
| Market cap | 944,065 |
| Beta (5Y monthly) | 1.64 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9260 |
| Earnings date | 25 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyEkso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call Transcript
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Q1 2024 Earnings Call Transcript April 29, 2024 Ekso Bionics Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Ekso Bionics’ First Quarter 2024 Financial Results Call. At this […]
- Thomson Reuters StreetEvents
Q1 2024 Ekso Bionics Holdings Inc Earnings Call
Q1 2024 Ekso Bionics Holdings Inc Earnings Call
GlobeNewswireEkso Bionics Announces First Quarter 2024 Financial Results
SAN RAFAEL, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three months ended March 31, 2024. Recent Highlights and Accomplishments Received final payment determination for Medicare reimbursement from the Centers for Medicare & Medicaid Services (“CMS”) for Ekso Indego PersonalReported revenues of $3.8 mill
